Youhai Harry Chen, Ph.D., M.Sc., M.B

International Scholar

  •  Emeritus Professor of Pathology | Shenzehen Institute of Advanced Technology
  •  China
  •   Medical Education | Pharmaceutical Education

Languages: English (fluent), Chinese (fluent)

Bio statement

Dr. Chen received his M.B. and M.Sc. from Shandong University, and his Ph.D. degree from the University of Manitoba, Canada. After a postdoctoral training at Harvard Medical School, he joined the faculty of the University of Pennsylvania in 1995. He was a Professor of Pathology and Laboratory Medicine until 2020. In 2021, he became Chair Professor and Dean of School of Pharmaceutical Sciences at Shenzhen Institute of Advanced Technology, Shenzhen, China. He has authored more than 150 research articles, and chaired a number of academic and administrative committees at academic or pharmaceutical institutions.

Recent global health projects

1. Dr. Chen's research focused on inflammation and cancer, both of which are related to global health

Selected publications

TIPE3 is the transfer protein of lipid second messengers that promote cancer.
Fayngerts Svetlana A, Wu Jianping, Oxley Camilla L, Liu Xianglan, Vourekas Anastassios, Cathopoulis Terry, Wang Zhaojun, Cui Jian, Liu Suxia, Sun Honghong, Lemmon Mark A, Zhang Lining, Shi Yigong, Chen Youhai H, Cancer Cell 26(4): 465-78, 2014, PMID:25242044

c-Rel is a myeloid checkpoint for cancer immunotherapy
Ting Li, Xinyuan Li, Ali Zamani, Wei Wang, Chin-Nien Lee, Mingyue Li, George Luo, Emily Eiler, Honghong Sun, Sankar Ghosh, Jian Jin, Ramachandran Murali, Qingguo Ruan, Weiyun Shi & Youhai H. Chen, Nature Cancer 1(): 507-517; https://rdcu.be/b4ffJ, 2020